Last updated: August 17, 2026

Introduction: Stem Cells in Spinal Disc Repair Spinal disc herniations are a common spinal disorder that can cause significant pain and disability. Traditional treatments for disc herniations, such as surgery and physical therapy, have limited efficacy and can be associated with significant complications. Stem cell therapy has emerged as a promising new treatment option for disc herniations, offering the potential for tissue regeneration and pain relief.

Pathophysiology of Spinal Disc Herniations

Spinal discs are located between the vertebrae and act as shock absorbers. They consist of a tough outer layer (annulus fibrosus) and a soft, gelatinous center (nucleus pulposus). Disc herniation occurs when the nucleus pulposus pushes through the annulus fibrosus, causing compression of the spinal cord or nerve roots. This compression can lead to pain, numbness, weakness, and other symptoms.

Role of Stem Cells in Tissue Regeneration

Stem cells are unspecialized cells that have the ability to differentiate into a variety of cell types. This makes them ideal for use in tissue regeneration, as they can be transplanted into damaged tissue and differentiate into the specific cell types needed for repair. In the case of disc herniations, stem cells can differentiate into annulus fibrosus and nucleus pulposus cells, helping to restore the structural integrity of the disc.

Preclinical Studies on Stem Cell Therapy for Disc Herniations

Preclinical studies in animal models have demonstrated the potential of stem cell therapy for disc herniations. In these studies, stem cells have been shown to promote disc regeneration, reduce pain, and improve neurological function. These findings have paved the way for clinical trials to evaluate the safety and efficacy of stem cell therapy in humans.

Clinical Trials Utilizing Stem Cells for Disc Repair

Several clinical trials have been conducted to evaluate the use of stem cells for disc herniation repair. These trials have shown promising results, with some patients experiencing significant pain relief and improved function. However, further research is needed to determine the optimal stem cell source, dosage, and delivery method for this therapy.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories:   Chronic Bronchitis  Stroke Transient Ischemia Attackanesthesiology conferencesantiradiation drugAtrophic GastritisAutoimmune Thyroiditiscardiologycardiology conference 2018Chronic Heart Failure Chronic Kidney Failureclinical trialsCouperose Rosacea Stem Cell Therapycoursecra certificationdoctor conferencefrozen embryo transfergeriatrics conferencesHashimoto thyroidneurologyoncologyPainpain conferencesPancreatitis DietPanic DisorderParkinson’s diseasePotential Risks of Stem Cell TherapiesStammzellbehandlungStem cell in EuropeStem Cell MarketStem Cell therapyStem Cell Therapy & Clinical ResearchStem Cell Treatmentstem cellsStem Cells Clinical Trialsstem cells therapyStem cells therapy of cerebral palsystem cells treatmentstem cells warning

NBScience

contract research organization

WhatsApp